MALARONE - 0173-0675-02 - (atovaquone and proguanil hydrochloride)

Alphabetical Index


Drug Information of MALARONE

Product NDC: 0173-0675
Proprietary Name: MALARONE
Non Proprietary Name: atovaquone and proguanil hydrochloride
Active Ingredient(s): 250; 100    mg/1; mg/1 & nbsp;   atovaquone and proguanil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of MALARONE

Product NDC: 0173-0675
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021078
Marketing Category: NDA
Start Marketing Date: 20000726

Package Information of MALARONE

Package NDC: 0173-0675-02
Package Description: 24 TABLET, FILM COATED in 1 DOSE PACK (0173-0675-02)

NDC Information of MALARONE

NDC Code 0173-0675-02
Proprietary Name MALARONE
Package Description 24 TABLET, FILM COATED in 1 DOSE PACK (0173-0675-02)
Product NDC 0173-0675
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name atovaquone and proguanil hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20000726
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Strength Number 250; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]

Complete Information of MALARONE


General Information